Author:
Guaraldi Giovanni,Zona Stefano,Orlando Gabriella,Carli Federica,Stentarelli Chiara,Luzi Kety,Garlassi Elisa,Menozzi Marianna,Bagni Pietro,Adorni Fulvio
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),General Medicine
Reference29 articles.
1. Fisac C, Fumero E, Crespo M, et al. Metabolic benefits 24 months after replacing a protease inhibitor with abacavir, efavirenz or nevirapine. AIDS 2005; 19: 917–25
2. Fisac C, Virgili N, Ferrer E, et al. A comparison of the effects of nevirapine and nelfinavir on metabolism and body habitus in antiretroviral-naive human immunodeficiency virus-infected patients: a randomized controlled study. J Clin Endocrinol Metab 2003; 88: 5186–92
3. van Vonderen MG, van Agtmael MA, Hassink EA, et al. Zidovudine/lamivudine for HIV-1 infection contributes to limb fat loss. PLoS One 2009; 4: e5647
4. DHSS. Panel on Antiretroviral Guidelines for adults and adolescents. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Department of Health and Human Services; 2008 Nov 3: 1–139
5. EACS. European AIDS Clinical Society (EACS) guidelines 2008. Guidelines for the clinical management and treatment of HIV infected adults in Europe. Version 4: Paris, October 2008
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献